GARDEN CITY, NY, Oct. 17, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth-oriented and diversified diagnostics, genomics and biotech company, contiguous announced that its wholly owned subsidiary, Nebula Genomics, Inc., has added Russ B. Altman, M.D., Ph.D to its Advisory Board. Dr. Altman is the Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and Computer Science, and past seat of the Bioengineering Department astatine Stanford University. Dr. Altman is the 2nd subordinate of Nebula’s Advisory Board and joins Dr. George Church, Nebula’s Founder and Advisory Board Chairman. Nebula Genomics, a planetary person successful direct-to-consumer full genome sequencing, has achieved important twelvemonth implicit twelvemonth growth. Dr. Altman’s expertise volition enactment continued enlargement done thought leadership, manufacture cognition and strategical guidance.
“I americium honored to invited Russ to our technological advisory board” said Ted Karkus, ProPhase Lab’s Chief Executive Officer. “We look guardant to leveraging his wide experience, on with the insights helium volition provide, arsenic we proceed to absorption connected executing our strategy with respect to our idiosyncratic genomics business.”
“I americium thrilled to articulation the advisory committee of Nebula” Dr. Altman stated. Nebula has a focused committedness to utilizing genomics to amended the wellness of individuals, portion maintaining the information and privateness of their idiosyncratic information. They already connection compelling products successful this area, and I americium excited to prosecute successful discussions astir caller products that volition beforehand their vision.”
Dr. Altman holds an A.B. from Harvard College, an M.D. from Stanford Medical School, and a Ph.D. successful aesculapian accusation sciences from Stanford University. He is committee certified successful interior medicine and successful objective informatics. He received the Presidential Early Career Award for Scientists and Engineers and a National Science Foundation Faculty Early Career Development (CAREER) Program award. He is simply a chap of the American College of Physicians (ACP), the American College of Medical Informatics (ACMI), the American Institute for Medical and Biological Engineering (AIMBE), and the American Association for the Advancement of Science (AAAS). He is simply a subordinate of the National Academy of Medicine. He is simply a past president, founding committee member, and chap of the International Society for Computational Biology (ISCB) and a past president of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). He has chaired the subject committee advising the FDA commissioner, served connected the NIH Director’s Advisory Committee, and co-chaired the IOM Drug Forum. He is an organizer of the yearly Pacific Symposium connected Biocomputing.
His superior probe interests are successful the exertion of computing exertion (artificial quality [AI], information science, and informatics) to problems applicable to medicine. Dr. Altman is peculiarly funny successful informatics methods for knowing cause enactment astatine the molecular, cellular, organism, and colonisation levels. His enactment focuses connected however quality familial saltation affects cause response. He besides analyzes biologic molecules to recognize drugs’ actions, interactions, and adverse events. Dr. Altman helps pb a U.S. Food and Drug Administration (FDA)–supported Center of Excellence successful Regulatory Science and Innovation. He is the founding exertion of the Annual Review of Biomedical Data Science and hosts a podcast entitled “The Future of Everything.”
Dr. Church is 1 of the astir respected and prolific individuals successful the tract of genomics. Dr. Church is simply a Professor of Genetics astatine Harvard Medical School and Professor of Health Sciences and Technology astatine Harvard University and the Massachusetts Institute of Technology (MIT). His pioneering enactment has contributed to the improvement of DNA sequencing and genome engineering technologies for which helium has received aggregate awards including the 2011 Bower Award and Prize for Achievement successful Science from the Franklin Institute and predetermination to the National Academy of Science and Engineering. He served arsenic the Director of the U.S. Department of Energy Technology Center and Director of the National Institutes of Health Center for Excellence successful Genomics Science. He has co-authored implicit 550 publications, much than 150 patents, and a publication titled “Regenesis: How Synthetic Biology Will Reinvent Nature and Ourselves”. He besides initiated the Personal Genome Project and has started respective companies.
ProPhase Labs precocious announced plans to importantly grow its Garden City, New York office and physique a caller genomics laboratory outfitted with industry-leading adjacent procreation sequencing to execute full genome sequencing and an array of familial trial offerings for some objective and probe purposes.
About ProPhase Labs
ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase”) is simply a maturation oriented and diversified diagnostics, genomics and biotech company. The Company seeks to leverage its CLIA laboratory services to supply full genome sequencing and research, nonstop to consumers, arsenic it builds a genomics database to beryllium utilized for further research. The Company provides accepted CLIA molecular laboratory services, including COVID-19 testing. The Company besides operates a state-of-the-art declaration manufacturing subsidiary and offers the TK Supplements enactment of dietary supplements, which are distributed successful food, cause and wide stores passim the country.
ProPhase Diagnostics, Inc., a wholly-owned subsidiary of ProPhase, offers a wide array of objective diagnostic and investigating services astatine its CLIA certified laboratories including state-of-the-art polymerase concatenation absorption (PCR) investigating for SARS-CoV-2 (COVID-19). Critical to COVID-19 testing, ProPhase Diagnostics provides accelerated turnaround times for results. ProPhase Diagnostics besides offers best-in-class accelerated antigen and antibody/immunity tests to broaden its COVID-19 investigating beyond RT-PCR testing. The Company has announced plans for enlargement of its Garden City, New York laboratory to see accepted objective investigating and genomics testing.
ProPhase Precision Medicine, Inc., a wholly-owned subsidiary of ProPhase, focuses connected genomics investigating technologies, a broad method for analyzing full genomes, including the genes and chromosomes successful DNA. The information obtained from genomic investigating tin assistance to place inherited disorders and tendencies, assistance foretell illness risk, assistance place expected cause response, and qualify familial mutations, including those that thrust crab progression. The Company presently offers Nebula Genomics full genome sequencing products direct-to-consumer online, with plans to merchantability successful food, cause and wide (FDM) stores and to supply investigating for universities conducting genomic research.
ProPhase BioPharma, Inc. (PBIO), a wholly owned subsidiary of ProPhase, was formed for the licensing, improvement and commercialization of caller drugs and compounds including Equivir and Equivir G and 2 tiny molecule PIM kinase inhibitors, Linebacker LB-1 and LB-2, with plans to prosecute improvement and commercialization of LB-1 arsenic a crab co-therapy.
ProPhase Labs has decades of acquisition researching, developing, manufacturing, distributing, marketing, and selling OTC user healthcare products and dietary supplements nether the TK Supplements® marque and Phamaloz declaration manufacturing subsidiary.
ProPhase Labs actively pursues strategical investments and acquisition opportunities for different companies, technologies, and products.
For much information, sojourn www.ProPhaseLabs.com.
Media Relations and Institutional Investor Contact:
ProPhase Labs, Inc.
267-880-1111
investorrelations@prophaselabs.com
Retail Investor Relations Contact:
Renmark Financial Communications
John Boidman
514-939-3989
Jboidman@renmarkfinancial.com
English (US)